DJIA 15,914.74 -99.64 -0.62%
NASDAQ 4,283.59 14.83 0.35%
S&P 500 1,851.86 -0.35 -0.02%
market minute promo

MannKind Corp (NASDAQ: MNKD)

0.93 -0.04 (-3.75%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MNKD $0.93 -3.75%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.95
Previous Close $0.97
Daily Range $0.90 - $1.04
52-Week Range $0.64 - $7.88
Market Cap $382.3M
P/E Ratio -3.03
Dividend (Yield) $0.00 (0.0%)
Volume 4,018,290
Average Daily Volume 8,376,045
Current FY EPS -$0.28




Drug Makers

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website:

News & Commentary Rss Feed

Why MannKind Corporation Is Popping Today

News of a definitive transition date puts investors in a good mood.

Sanofi Tops Q4 Earnings, Revenues Fall Y/Y, Gives 2016 View

Notable Wednesday Option Activity: MNKD, TLRD, CBI

Why MannKind Corporation's Shares Plunged 31% in January

It was a crazy month for the beaten-down biotech.

MannKind: Naso Oblongo Syndrome?

MannKind Fails Twitter Like It Does Afrezza

MannKind's (MNKD) Investor Conference Call (Transcript)

Will MannKind (MNKD) Continue to Surge Higher?

Vetr Top Raters Upgrade MannKind To 5-Star Stock

Should You Bet On A MannKind Sale?

See More MNKD News...

MNKD's Top Competitors

MNKD $0.93 (-3.75%)
Current stock: MNKD
AMGN $144.81 (1.15%)
Current stock: AMGN
GILD $87.77 (0.60%)
Current stock: GILD
BIIB $252.20 (0.88%)
Current stock: BIIB